134 related articles for article (PubMed ID: 2415118)
1. Trapidil derivatives as potent inhibitors of cyclic AMP phosphodiesterase from heart and coronary arteries.
Bartel S; Tenor H; Krause EG
Biomed Biochim Acta; 1985; 44(5):K31-5. PubMed ID: 2415118
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of cardiovascular action of trapidil.
Satoh K; Yamashita S; Endoh M; Taira N
Arzneimittelforschung; 1980; 30(8):1264-8. PubMed ID: 6254546
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of thromboxane A2 production by trapidil and trapidil derivatives in the arachidonic acid-injected rat.
Heinroth-Hoffmann I; Hauser A; Mest HJ
Prostaglandins Leukot Med; 1987 Dec; 30(2-3):87-92. PubMed ID: 2827194
[TBL] [Abstract][Full Text] [Related]
4. [The action mechanism of trapidil (Rocornal)].
Lampe D; Mai I; Busse E
Pharmazie; 1975 Dec; 30(12):807-8. PubMed ID: 176671
[No Abstract] [Full Text] [Related]
5. Trapidil and other 5-triazolo-(1, 5-alpha)-pyrimidine derivatives as calcium channel blockers in 108CC5 cells.
Hering S; Bodewei R; Schubert B; Krause EG; Wollenberger A
Biomed Biochim Acta; 1985; 44(5):K37-41. PubMed ID: 2415119
[TBL] [Abstract][Full Text] [Related]
6. Effects of trapidil on electrical activities of canine ventricular muscle.
Yanagisawa T; Iijima T; Taira N
Arzneimittelforschung; 1980; 30(8):1268-71. PubMed ID: 6254547
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo inhibitory effects of propentofylline on cyclic AMP phosphodiesterase activity.
Nagata K; Ogawa T; Omosu M; Fujimoto K; Hayashi S
Arzneimittelforschung; 1985; 35(7):1034-6. PubMed ID: 2996562
[TBL] [Abstract][Full Text] [Related]
8. [Effect of psychotropic preparations on cyclic AMP phosphodiesterase activity in the rat cerebral cortex].
Shchekoldina TG; Vatolkina OE; Libinzon RE
Vopr Med Khim; 1978; 24(2):166-9. PubMed ID: 208286
[TBL] [Abstract][Full Text] [Related]
9. Methylxanthine inhibitors of phosphodiesterases.
Wells JN; Miller JR
Methods Enzymol; 1988; 159():489-96. PubMed ID: 2457788
[No Abstract] [Full Text] [Related]
10. Inhibition of cyclic AMP phosphodiesterase by 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)] ethyl ester 5-methyl ester hydrochloride (YC-93), a potent vasodilator.
Sakamoto N; Terai M; Takenaka T; Maeno H
Biochem Pharmacol; 1978; 27(8):1269-74. PubMed ID: 81059
[No Abstract] [Full Text] [Related]
11. Inhibition of thromboxane B2 formation of blood platelets by trapidil and other s-triazolo(1,5-a)pyrimidine derivatives.
Block HU; Hoffmann-Heinroth I; Taube C; Niebisch M; Mest HJ
Prostaglandins Leukot Med; 1987 Dec; 30(2-3):77-86. PubMed ID: 2827193
[TBL] [Abstract][Full Text] [Related]
12. Tissue selective inhibition of cyclic nucleotide phosphodiesterase by denbufylline.
Wilke R; Arch JR; Nicholson CD
Arzneimittelforschung; 1989 Jun; 39(6):665-7. PubMed ID: 2476135
[TBL] [Abstract][Full Text] [Related]
13. [Inhibition of cyclic nucleotide phosphodiesterase from rabbit heart by hydroxypyridines].
Polyansky NB; Smirnov LD; Shvedova AA; Kagan VE; Tkachuk VA
Vopr Med Khim; 1983; 29(1):123-7. PubMed ID: 6301154
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of 3',5'-cyclic nucleotide 3'-phosphohydrolase by a novel 1',2'-cyclic nucleotide.
Nair V; Wiechert RJ; Young DA
J Cyclic Nucleotide Res; 1982; 8(3):181-90. PubMed ID: 6187785
[No Abstract] [Full Text] [Related]
15. Decrease of platelet aggregation and spreading via inhibition of the cAMP phosphodiesterase by trapidil.
Mazurov AV; Menshikov MYu ; Leytin VL; Tkachuk VA; Repin VS
FEBS Lett; 1984 Jul; 172(2):167-71. PubMed ID: 6086387
[TBL] [Abstract][Full Text] [Related]
16. The trapidil derivative AR 12456 protects against serum hyperlipidemia in guinea pigs.
Beitz J; Riedel A; Beitz A; Giessler C; Kittel A; Mest HJ
J Lipid Mediat; 1991; 3(2):177-86. PubMed ID: 1665714
[TBL] [Abstract][Full Text] [Related]
17. A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties.
Alvarez R; Banerjee GL; Bruno JJ; Jones GL; Littschwager K; Strosberg AM; Venuti MC
Mol Pharmacol; 1986 Jun; 29(6):554-60. PubMed ID: 3012320
[TBL] [Abstract][Full Text] [Related]
18. Mechanism by which psychotropic drugs inhibit adenosine cyclic 3',5'-monophosphate phosphodiesterase of brain.
Levin RM; Weiss B
Mol Pharmacol; 1976 Jul; 12(4):581-9. PubMed ID: 183095
[No Abstract] [Full Text] [Related]
19. Trapidil derivatives as potential antiatherosclerotic drugs.
Giessler C; Fahr A; Tertov VV; Kudryashov SA; Orekhov AN; Smirnov VN; Mest HJ
Arzneimittelforschung; 1987 May; 37(5):538-41. PubMed ID: 3040019
[TBL] [Abstract][Full Text] [Related]
20. Interaction of amoscanate with the cyclic AMP-phosphodiesterases from Schistosoma mansoni, Onchocerca volvulus and bovine heart.
Walter RD; Albiez EJ
Tropenmed Parasitol; 1984 Jun; 35(2):78-80. PubMed ID: 6087521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
